Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.

NCT03161353 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

377

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Perjeta
DRUG: Herceptin
DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Letrozole
DRUG: Tamoxifen

Sponsor

MedSIR